How to evaluate Stock solution stability according to EMA guideline [Bioanalytics]

posted by chandru – India, 2018-05-27 21:26 (1239 d 05:45 ago) – Posting: # 18819
Views: 2,335

Hi Ohlbe,

Is it ok to evaluate working solution stability according to FDA guidance May 2018 at LQC and HQC level.

As they have spoken about stock solution stability which has to be done at LQC and HQC level. Does it apply for working solution stability?


Thanks,
Chandru

Complete thread:

Activity
 Admin contact
21,731 posts in 4,544 threads, 1,543 registered users;
online 5 (0 registered, 5 guests [including 5 identified bots]).
Forum time: Monday 03:12 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5